Loading...
Rheumatic disease and COVID-19: epidemiology and outcomes
Since the outset of the COVID-19 pandemic, numerous risk factors for severe disease have been identified. Whether patients with rheumatic diseases, especially those receiving DMARDs, are at an increased risk of SARS-CoV-2 infection or severe COVID-19 disease remains unclear, although epidemiological...
Saved in:
| Published in: | Nat Rev Rheumatol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group UK
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7747184/ https://ncbi.nlm.nih.gov/pubmed/33339986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41584-020-00562-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|